| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14712598.2012.666522 |
| P698 | PubMed publication ID | 22500945 |
| P50 | author | Lyn S Chitty | Q56526261 |
| P2093 | author name string | Lucy Jenkins | |
| Celine Lewis | |||
| Melissa Hill | |||
| Stephanie Allen | |||
| Rob G Elles | |||
| P2860 | cites work | Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield | Q28744238 |
| Integrated regional genetic services: current and future provision | Q33805228 | ||
| First-trimester determination of fetal gender by ultrasound | Q33865900 | ||
| Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis | Q34028063 | ||
| The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. | Q34933117 | ||
| How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network | Q36834004 | ||
| Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review | Q36927303 | ||
| EuroGentest: DNA-based testing for heritable disorders in Europe. | Q37060165 | ||
| The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma | Q44545615 | ||
| Non-invasive prenatal determination of fetal sex: translating research into clinical practice | Q44982893 | ||
| Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia | Q45855202 | ||
| Reliability of fetal sex determination using maternal plasma. | Q51596658 | ||
| Fetal gender assignment by first-trimester ultrasound. | Q51818078 | ||
| Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. | Q51836356 | ||
| Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. | Q54574187 | ||
| Y chromosome detection by Real Time PCR and pyrophosphorolysis-activated polymerisation using free fetal DNA isolated from maternal plasma | Q56001882 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England | Q57839594 | ||
| How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom | Q57950555 | ||
| P433 | issue | sup1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United Kingdom | Q145 |
| sex-determination system | Q594595 | ||
| P304 | page(s) | S119-S126 | |
| P577 | publication date | 2012-04-16 | |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | Implementing noninvasive prenatal fetal sex determination using cell-free fetal DNA in the United Kingdom | |
| P478 | volume | 12 |
| Q35780095 | Direct to consumer testing in reproductive contexts--should health professionals be concerned? |
| Q51381812 | Implementing Non-Invasive Prenatal Diagnosis (NIPD) in a National Health Service Laboratory; From Dominant to Recessive Disorders. |
| Q53091843 | Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon. |
| Q36895493 | Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage |
| Q37745036 | Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage |
| Q26764809 | Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues |
| Q38549770 | Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA |
| Q48240788 | Noninvasive prenatal testing: the paradigm is shifting rapidly |
| Q38099617 | The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made |
| Q37333449 | Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice? |
Search more.